Uncategorized A look of the major listed cell immunotherapy companies in China

A look of the major listed cell immunotherapy companies in China

The summer of 2017 is the start of the golden age for cell immunotherapy. Since the end of June, there is no shortage of attention in this red-hot market. On June 29th, Sanpower Group, the Chinese pharma giant, has announced its acquisition of Dendreon with $819 million. The core product of the latter is the …

Read Article Read More

Uncategorized Chinese biopharmas are marching into the United States market: A look at all US-listed Chinese biologics companies

Chinese biopharmas are marching into the United States market: A look at all US-listed Chinese biologics companies

On September 21st, Zai Lab, the Chinese biopharma start-up, has officially listed in the United States Nasdaq global market, bagged a total of $150 million. On the same day, its stock rose 55.17%, amount to $27.93 per share. Zai Lab is not the first Chinese biopharmaceutical company which has completed an IPO in the United …

Read Article Read More

Uncategorized Medical laboratory diagnostics giants are facing a new round of expansions

Medical laboratory diagnostics giants are facing a new round of expansions

KingMed Diagnostics, Guangzhou based medical laboratory diagnostics giant, has officially listed in the Shanghai Stock Exchange on September 8th, marking the beginning of the Chinese third-party medical diagnostics industry holding hands with the capital market. KingMed Diagnostics, established in 2003, is an independent medical laboratory specializing in third-party medical testings and pathological diagnoses. Its main …

Read Article Read More